Sorry, you need to enable JavaScript to visit this website.

BENEFIX® (nonacog alfa) Nonclinical Toxicology

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

BeneFIX has been shown to be nonmutagenic in the Ames assay and non-clastogenic in a chromosomal aberrations assay. No investigations on carcinogenesis or impairment of fertility have been conducted.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No